Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Dellapasqua

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Cancer Treatment and Research|July 14, 2009
Investigations after adjuvant therapySilvia Dellapasqua
Expert Opinion on Drug Metabolism & Toxicology|January 26, 2010
LetrozoleSilvia Dellapasqua, Marco Colleoni
European Journal of Cancer (Oxford, England : 1990)|February 5, 2005
The choice of systemic adjuvant therapy in receptor-positive early breast cancerSilvia Dellapasqua, Monica Castiglione-Gertsch
Nature Clinical Practice. Oncology|September 1, 2005
Ovarian ablation, a perennial technique still not well understoodSilvia Dellapasqua, Monica Castiglione-Gertsch
Breast (Edinburgh, Scotland)|September 29, 2005
Adjuvant endocrine therapies for postmenopausal women with early breast cancer: standards and notSilvia Dellapasqua, Monica Castiglione-Gertsch
European Journal of Cancer (Oxford, England : 1990)|October 29, 2005
Why did the study fail?Silvia Dellapasqua, Monica Castiglione-Gertsch
Nature Clinical Practice. Oncology|November 3, 2006
Focusing on physical function limitations in elderly women surviving cancer: any opportunity for improvement?Silvia Dellapasqua, Marco Colleoni, Aron Goldhirsch
Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant therapies for special types of breast cancerMarco Colleoni, Leila Russo, Silvia Dellapasqua
Tumori|April 16, 2009
Metronomic chemotherapy in elderly patients: do risks exceed benefits in some patients?Diana Crivellari, Marco Colleoni, Silvia Dellapasqua, et al.
The Oncologist|September 4, 2007
New criteria for selecting elderly patients for breast cancer adjuvant treatment studiesSilvia Dellapasqua, Marco Colleoni, Monica Castiglione, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Cancer Treatment and Research|July 14, 2009
Investigations after adjuvant therapySilvia Dellapasqua
Expert Opinion on Drug Metabolism & Toxicology|January 26, 2010
LetrozoleSilvia Dellapasqua, Marco Colleoni
European Journal of Cancer (Oxford, England : 1990)|February 5, 2005
The choice of systemic adjuvant therapy in receptor-positive early breast cancerSilvia Dellapasqua, Monica Castiglione-Gertsch
Nature Clinical Practice. Oncology|September 1, 2005
Ovarian ablation, a perennial technique still not well understoodSilvia Dellapasqua, Monica Castiglione-Gertsch
Breast (Edinburgh, Scotland)|September 29, 2005
Adjuvant endocrine therapies for postmenopausal women with early breast cancer: standards and notSilvia Dellapasqua, Monica Castiglione-Gertsch
European Journal of Cancer (Oxford, England : 1990)|October 29, 2005
Why did the study fail?Silvia Dellapasqua, Monica Castiglione-Gertsch
Nature Clinical Practice. Oncology|November 3, 2006
Focusing on physical function limitations in elderly women surviving cancer: any opportunity for improvement?Silvia Dellapasqua, Marco Colleoni, Aron Goldhirsch
Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant therapies for special types of breast cancerMarco Colleoni, Leila Russo, Silvia Dellapasqua
Tumori|April 16, 2009
Metronomic chemotherapy in elderly patients: do risks exceed benefits in some patients?Diana Crivellari, Marco Colleoni, Silvia Dellapasqua, et al.
The Oncologist|September 4, 2007
New criteria for selecting elderly patients for breast cancer adjuvant treatment studiesSilvia Dellapasqua, Marco Colleoni, Monica Castiglione, et al.
Pageof 5